Evidence indicates, for example, that chemokines such as CCL5, CCL7, CXCL8 act via CCRs on myeloid-derived suppressor cells (MDSCs) to form an inhibitory tumor microenvironment that promotes tumor pathogenesis, progression and resistance [21–23]. This evidence concerns the gene CCL7 and neoplasm.